Debate 1: Lurbinectedin: Best to Use As 2nd Line Therapy? (IASLC-WCLC 2026) - May 30, 2026 - Abstract #ES03.02; Pres time: Sep 13, 2026; 12:14 PM - 12:26 PM; Location: Room 103, Grand Ballroom, 1F; No abstract available
Lung Cancer • Small Cell Lung Cancer • Solid Tumor
|